JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
JMP Securities Upgrades TrueCar (TRUE) to Market Outperform
-
JMP Securities Downgrades Gramercy Property Trust (GPT) to Market Perform
-
JMP Securities Downgrades Columbia Property Trust (CXP) to Market Perform
-
Pre-Open Stock Movers 01/06: (ETRM) (OGXI) (STML) Higher; (RT) (GIII) (REGN) Lower (more...)
-
Sarepta Therapeutics (SRPT) PT Lowered to $65 at JMP Securities Following Update, Survey; Sees Upside to ~$160
-
JMP Securities Downgrades Halyard Health (HYH) to Market Perform
-
JMP Securities Upgrades Integra LifeSciences (IART) to Market Outperform
-
JMP Securities Upgrades Zafgen (ZFGN) to Market Outperform
-
Moelis & Company Prices Public Offering of Class A Common Stock
-
Model N Completes Acquisition of Revitas, Inc.
-
Pre-Open Stock Movers 01/04: (EVOK) (CBAY) (OCUL) Higher; (AGRX) (ACUR) (ENSG) Lower (more...)
-
JMP Securities Downgrades The Ensign Group Inc. (ENSG) to Market Underperform, Sets $18 PT
-
JMP Securities Starts Madrigal Pharmaceuticals (MDGL) at Market Outperform
-
JMP Securities Upgrades Barracuda Networks (CUDA) to Market Perform
-
JMP Securities Downgrades Innocoll (INNL) to Market Perform; XARACOLL Approval Delayed at Least 6-12 Months
-
AppDynamics Files Registration Statement for Proposed Initial Public Offering
-
AppDynamics (APPD) Files $100M IPO
-
JMP Securities Reiterates Market Perform on Sabra Health Care REIT (SBRA)
-
JMP Securities Reiterates Market Outperform on Strongbridge Biopharma (SBBP) Following Acquisition of Keveyis Rights
-
JMP Securities Maintains $49 PT on Aerie Pharma (AERI) Despite Rhopressa NDA Delay
-
Strongbridge Biopharma (SBBP) Enters $35M Securities Purchase Agreement
-
Strongbridge Biopharma plc Announces $35 Million Equity Financing
-
JMP Securities Cuts Price Target on Red Hat (RHT) Following Mixed 3Q
-
JMP Securities Downgrades Advanced Accelerator Applications S.A. (AAAP) to Market Perform
-
JMP Maintains View on Vertex (VRTX) Amid 'Comparable' Data from Competitor Galapagos
-
JMP Securities Downgrades Allied World Assurance (AWH) to Market Perform
-
Terreno Realty (TRNO) Files to Offer $150M in Common Stock
-
JMP Securities Upgrades Veeva Systems (VEEV) to Market Outperform
-
JMP Securities Upgrades BioCryst Pharma (BCRX) to Market Outperform
-
Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
-
Model N (MODN) to Acquire Revitas
-
Model N Signs Definitive Agreement to Acquire Revitas
-
Whitestone REIT Completes Disposition of Non-Core Assets, Advancing the Transformation of Whitestone into a Pure-Play, Community Centered Retail REIT
-
JMP Securities Starts Acuity Brands (AYI) at Market Underperform
-
JMP Securities Starts Cree (CREE) at Market Outperform
-
Blueprint Medicines (BPMC) Prices $125M Common Stock Offering
-
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
-
Ladder Capital (LADR) Prices 10M Share Secondary Stock Offering for Proceeds of ~$136M
-
Blueprint Medicines (BPMC) to Offer $125M of Common Stock
-
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
-
JMP Securities Downgrades IntraLinks Holdings (IL) to Market Perform
-
JMP Securities Resumes Ryman Hospitality Properties (RHP) at Market Outperform
-
JMP Securities Downgrades Sotherly Hotels (SOHO) to Market Perform
-
VBL Therapeutics (VBLT) Reports $20M at the Market Offering of Ordinary Shares
-
JMP Securities Starts Parkway Properties (PKY) at Market Outperform
-
JMP Securities Starts Myovant Sciences Ltd. (MYOV) at Market Outperform
-
JMP Securities Resumes/Downgrades Resource Capital Corp (RSO) to Market Underperform
-
JMP Securities Downgrades Evercore Partners (EVR) to Market Perform
-
Aclaris Therapeutics (ACRS) Prices 4M Stock Offering at $22.75/Share
-
Aclaris Announces Pricing of Public Offering of Common Stock

